 您的位置：对照品 > 对照品 > 国家对照品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：H942233 |
| 产品名称：(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyri |
| 产品CAS：2024557-22-8 |
| 规格含量：500mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
H942233 |
| 名称: |
(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-1,2-cyclopentanediol |
| CAS号: |
2024557-22-8 |
| 分子式: |
C₁₅H₂₃N₅O₅S |
| 外观: |
白色固体 |
| 分子量: |
385.44 |
| 溶解度: |
Choroform, Dichloromethane, Diethyl Ether, Ethyl Acetate |
| 种类: |
Building Blocks; Miscellaneous; |
| 应用: |
(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-1,2-cyclopentanediol is an intermediate in the synthesis of (1S,2S,3R,5S)-3-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol which is used in preparation of metaboltes of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. |
| 参考文献 |
|
|
|
|
|
|
![(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyri](/images/defaultpic.gif "(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyri")
